The store will not work correctly when cookies are disabled.
N-(4-acetyl-5-(pyridin-4-yl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide
ID: ALA4294466
Cas Number: 62236-04-8
PubChem CID: 12324987
Max Phase: Preclinical
Molecular Formula: C11H12N4O2S
Molecular Weight: 264.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)NC1=NN(C(C)=O)C(c2ccncc2)S1
Standard InChI: InChI=1S/C11H12N4O2S/c1-7(16)13-11-14-15(8(2)17)10(18-11)9-3-5-12-6-4-9/h3-6,10H,1-2H3,(H,13,14,16)
Standard InChI Key: ZCXPVLSZPSTSRE-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
14.6599 -4.4409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3267 -4.9277 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.9915 -4.4523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7426 -3.6713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9263 -3.6698 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7670 -4.7100 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3779 -4.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1534 -4.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2133 -3.3668 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4492 -3.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7852 -2.2615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6361 -3.0879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8820 -4.6847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2805 -4.1299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5013 -4.3737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3225 -5.1720 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9289 -5.7260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7058 -5.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 1 0
3 6 1 0
6 7 1 0
7 8 1 0
7 9 2 0
5 10 1 0
10 11 2 0
10 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
1 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 264.31 | Molecular Weight (Monoisotopic): 264.0681 | AlogP: 1.08 | #Rotatable Bonds: 1 |
Polar Surface Area: 74.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.69 | CX Basic pKa: 4.99 | CX LogP: 0.25 | CX LogD: 0.25 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.82 | Np Likeness Score: -1.37 |
References
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |